What strategies can be used to increase the percentage of patients who receive recommended RAS testing?
There are a number of ways to do this. One is to increase the level of education for pathologists for pathologists, as well as gastroenterologists and surgeons. So the folks who see the patients first before they send them to an oncologist, they need to know about the importance of this test. It should be more automatically thought of than it is today.
Unresectable Colon Cancer: Case 2
52-year-old woman newly diagnosed with metastatic CRC and is genotyped as part of her initial work up.
The Expanding Role of the Gut Microbiome in CRC
February 24th 2023Encouraging results in melanoma have led experts to explore the gut microbiome in colorectal cancer. The next hot topic in research may be the gut microbiome's role for the prevention, progression, and management of colorectal cancer.
Read More
The Impact of the Gut Microbiome in Young Patients With Colorectal Cancer
February 15th 2021In season 2, episode 2 of Targeted Talks, Cathy Eng, MD, speaks with Benjamin Weinberg, MD, about the gut microbiome, and how the presence of certain microbiota impact the onset and intensity of disease as well as the potential response to certain treatments.
Listen
Durable Response Seen With PD-1 Plus BRAF/MEK Inhibitor Combo in CRC
February 7th 2023Results of a study of dabrefenib, trametinib, and spartalizumab showed efficacy for the combination of a BRAF inhibitor, a MEK inhibitor, and an anti–PD-1 agent in patients with BRAF V600-mutated colorectal cancer.
Read More
2 Clarke Drive
Cranbury, NJ 08512